Food deserts and stroke risk, physical activity in Parkinson’s disease, rimegepant for migraine
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the relationship between income, “food deserts,” and stroke risk; why staying active may reduce cognitive decline in patients with Parkinson's disease; and how initiating rimegepant for migraine could help reduce opioid and butalbital use.
--------
4:51
--------
4:51
Parkinson’s and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a promising blood test to distinguish Parkinson’s disease from dementia with Lewy bodies, how CAR T-cell therapies are showing potential for patients with glioblastoma, and a new wireless electroencephalogram device that can even monitor young children with epilepsy.
--------
4:27
--------
4:27
Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about whether small fiber neuropathy is an autoimmune disorder; Merit Cudkowicz, MD, MSc, FAAN, recipient of this year’s AAN Lifetime Achievement Award for Clinically Relevant Research; and how neurologist couples pursue work-life balance.
--------
3:52
--------
3:52
Divisive treatment for cluster headache, head positioning before thrombectomy, new series, “Neurology in America”
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about eptinezumab, a treatment for episodic cluster headache; how positioning the head flat before a thrombectomy benefited patients with large vessel occlusion stroke; and what rural neurology looks like in 2025, the first story in our new series, Neurology in America.
--------
4:10
--------
4:10
New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.
Brasil